Function
1
End Use
Certification

Search Results for "Functional Materials"

:9283

Special Cationic Surfactant Solid

Antistatic Agent Additive

Produced by Miyoshi Oil & Fat Co., Ltd.

In cardboard case of 10 kg net

Special Fatty Acid Ester

Highly Purified Ester

Produced by Miyoshi Oil & Fat Co., Ltd.

In drum of 170 kg net

Special Fatty Acid Ester Liquid

Highly Purified Ester

Produced by Miyoshi Oil & Fat Co., Ltd.

In pail can of 16 kg net

TRAMIN DF

Defoaming Excellence for Papermaking and Wastewater

Produced by Miyoshi Oil & Fat Co., Ltd.

 

SPINOL-Based Ligands 134850-100MG

(11aR)-10,11,12,13-Tetrahydro-5-Hydroxy-3,7-Di-1-Naphthalenyl-5-Oxide-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

100 mg net

SPINOL-Based Ligands 134906-100MG

(11aR)-10,11,12,13-Tetrahydro-5-Hydroxy-3,7-Di-2-Naphthalenyl-5-Oxide-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

100 mg net

SPINOL-Based Ligands 135843-100MG

(11aR)-10,11,12,13-Tetrahydro-5-Hydroxy-3,7-Di-9-Phenanthrenyl-5-Oxide-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

100 mg net

SPINOL-Based Ligands 134852-100MG

(11aR)-10,11,12,13-Tetrahydro-5-Hydroxy-3,7-Diphenyl-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

100 mg net

SPINOL-Based Ligands 135046-100MG

(11aR)-10,11,12,13-Tetrahydro-5-Hydroxy-5-Oxide-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

100 mg net

SPINOL-Based Ligands 134998-50MG

(11aR)-3,7-Bis([1,1'-Biphenyl]-4-yl)-10,11,12,13-Tetrahydro-5-Hydroxy-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

50 mg net

SPINOL-Based Ligands 135896-50MG

(11aR)-3,7-Bis(1-Pyrenyl)-10,11,12,13-Tetrahydro-5-Hydroxy-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

50 mg net

SPINOL-Based Ligands 134896-100MG

(11aR)-3,7-Bis[3,5-Bis(Trifluoromethyl)Phenyl]-10,11,12,13-Tetrahydro-5-Hydroxy-5-Oxide-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

100 mg net

SPINOL-Based Ligands 134898-100MG

(11aR)-3,7-Bis(3,5-Dimethylphenyl)-10,11,12,13-Tetrahydro-5-Hydroxy-5-Oxide-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

100 mg net

SPINOL-Based Ligands 134909-50MG

(11aR)-3,7-Bis((4-(1,1-Dimethylethyl)Phenyl)-10,11,12,13-Tetrahydro-5-Hydroxy-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

50 mg net

SPINOL-Based Ligands 135865-100MG

(11aR)-3,7-Bis(4-Chlorophenyl)-10,11,12,13-Tetrahydro-5-Hydroxy-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

100 mg net

SPINOL-Based Ligands 135845-50MG

(11aR)-3,7-Di-9-Anthracenyl-10,11,12,13-Tetrahydro-5-Hydroxy-5-Oxide-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

50 mg net

SPINOL-Based Ligands 134849-100MG

(11aS)-10,11,12,13-Tetrahydro-5-Hydroxy-3,7-Di-1-Naphthalenyl-5-Oxide-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

100 mg net

SPINOL-Based Ligands 134907-100MG

(11aS)-10,11,12,13-Tetrahydro-5-Hydroxy-3,7-Di-2-Naphthalenyl-5-Oxide-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

100 mg net

SPINOL-Based Ligands 135844-100MG

(11aS)-10,11,12,13-Tetrahydro-5-Hydroxy-3,7-Di-9-Phenanthrenyl-5-Oxide-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

100 mg net

SPINOL-Based Ligands 134851-100MG

(11aS)-10,11,12,13-Tetrahydro-5-Hydroxy-3,7-Diphenyl-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

100 mg net

SPINOL-Based Ligands 135047-100MG

(11aS)-10,11,12,13-Tetrahydro-5-Hydroxy-5-Oxide-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

100 mg net

SPINOL-Based Ligands 134997-50MG

(11aS)-3,7-Bis([1,1'-Biphenyl]-4-yl)-10,11,12,13-Tetrahydro-5-Hydroxy-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

50 mg net

SPINOL-Based Ligands 135897-50MG

(11aS)-3,7-Bis(1-Pyrenyl)-10,11,12,13-Tetrahydro-5-Hydroxy-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

50 mg net

SPINOL-Based Ligands 134897-100MG

(11aS)-3,7-Bis[3,5-Bis(Trifluoromethyl)Phenyl]-10,11,12,13-Tetrahydro-5-Hydroxy-5-Oxide-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

100 mg net

SPINOL-Based Ligands 134899-100MG

(11aS)-3,7-Bis(3,5-Dimethylphenyl)-10,11,12,13-Tetrahydro-5-Hydroxy-5-Oxide-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

100 mg net

SPINOL-Based Ligands 134908-50MG

(11aS)-3,7-Bis((4-(1,1-Dimethylethyl)Phenyl)-10,11,12,13-Tetrahydro-5-Hydroxy-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

50 mg net

SPINOL-Based Ligands 135866-100MG

(11aS)-3,7-Bis(4-Chlorophenyl)-10,11,12,13-Tetrahydro-5-Hydroxy-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

100 mg net

SPINOL-Based Ligands 135846-50MG

(11aS)-3,7-Di-9-Anthracenyl-10,11,12,13-Tetrahydro-5-Hydroxy-5-Oxide-Diindeno[7,1-De:1',7'-Fg][1,3,2]Dioxaphosphocin

Produced by Daicel Corporation

50 mg net

Chiral Phosphoric Acids 110171-100MG

(11bR)-2,6-Bis[3,5-Bis(Trifluoromethyl)Phenyl]-4-Hydroxy-4-Oxide-Dinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepin

Produced by Daicel Corporation

100 mg net

Chiral Phosphoric Acids 110251-100MG

(11bR)-2,6-Bis[3,5-Bis(Trifluoromethyl)Phenyl]-8,9,10,11,12,13,14,15-Octahydro-4-Hydroxy-4-Oxide-Dinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepin

Produced by Daicel Corporation

100 mg net

/ 310

2551–2580 of 9283 results